| (R)-noradrenaline | multiple interactions | ISO | RGD:2535 | 6480464 | [cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] which results in decreased susceptibility to Norepinephrine | CTD | PMID:15834289 |
| (S)-nicotine | decreases expression | ISO | RGD:737537 | 6480464 | Nicotine results in decreased expression of EDNRA mRNA | CTD | PMID:18247414 |
| 11-deoxycorticosterone | multiple interactions | ISO | RGD:2535 | 6480464 | [5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide binds to and results in decreased activity of EDNRA protein] inhibits the reaction [Desoxycorticosterone results in increased chemical synthesis of Reactive Oxygen Species] | CTD | PMID:16271043 |
| 11-deoxycorticosterone | affects response to substance | ISO | RGD:2535 | 6480464 | EDNRA protein affects the susceptibility to Desoxycorticosterone | CTD | PMID:12600921 |
| 11-deoxycorticosterone | multiple interactions | ISO | RGD:2535 | 6480464 | [Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of EDNRA protein | CTD | PMID:22431579 |
| 17beta-estradiol | increases expression | ISO | RGD:737537 | 6480464 | Estradiol results in increased expression of EDNRA mRNA | CTD | PMID:19943105 |
| 17beta-estradiol | multiple interactions | ISO | RGD:737537 | 6480464 | Tamoxifen inhibits the reaction [Estradiol results in increased expression of EDNRA mRNA] | CTD | PMID:19943105 |
| 2-naphthylamine | decreases expression | ISO | RGD:737537 | 6480464 | 2-Naphthylamine results in decreased expression of EDNRA mRNA | CTD | PMID:18247414 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | ISO | RGD:2535 | 6480464 | Puromycin Aminonucleoside results in increased expression of EDNRA mRNA | CTD | PMID:12972712 |
| 5-fluorouracil | affects response to substance | ISO | RGD:737537 | 6480464 | EDNRA protein affects the susceptibility to Fluorouracil | CTD | PMID:17032313 |
| actinomycin D | multiple interactions | ISO | RGD:2535 | 6480464 | Dactinomycin inhibits the reaction [Particulate Matter results in increased expression of EDNRA mRNA]; more ... | CTD | PMID:20561571 |
| aldosterone | multiple interactions | ISO | RGD:2535 | 6480464 | [cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]; more ... | CTD | PMID:18660453 |
| all-trans-retinoic acid | increases expression | ISO | RGD:737537 | 6480464 | Tretinoin results in increased expression of EDNRA mRNA | CTD | PMID:21934132 |
| aminoguanidine | multiple interactions | ISO | RGD:2535 | 6480464 | pimagedine inhibits the reaction [Isoproterenol results in increased expression of EDNRA mRNA] | CTD | PMID:18594475 |
| arsenic atom | affects expression | EXP | | 6480464 | Arsenic affects the expression of EDNRA mRNA | CTD | PMID:19654921 |
| benzo[a]pyrene | decreases expression | ISO | RGD:737537 | 6480464 | Benzo(a)pyrene results in decreased expression of EDNRA mRNA | CTD | PMID:18247414 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of EDNRA mRNA | CTD | PMID:22228805 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:2535 | 6480464 | Diethylhexyl Phthalate results in increased expression of EDNRA mRNA | CTD | PMID:20920545 |
| bosentan | multiple interactions | ISO | RGD:737537 | 6480464 | bosentan binds to and results in decreased activity of EDNRA protein | CTD | PMID:16219361 |
| bosentan | multiple interactions | ISO | RGD:2535 | 6480464 | bosentan binds to and results in decreased activity of EDNRA protein | CTD | PMID:15964565 |
| calcium atom | affects activity | ISO | RGD:2535 | 6480464 | Calcium affects the activity of EDNRA protein | CTD | PMID:12628492 |
| calcium(0) | affects activity | ISO | RGD:2535 | 6480464 | Calcium affects the activity of EDNRA protein | CTD | PMID:12628492 |
| carmustine | affects response to substance | ISO | RGD:737537 | 6480464 | EDNRA mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 |
| cisplatin | affects response to substance | ISO | RGD:737537 | 6480464 | EDNRA protein affects the susceptibility to Cisplatin | CTD | PMID:17032313 |
| cocaine | increases expression | ISO | RGD:737537 | 6480464 | Cocaine results in increased expression of EDNRA protein | CTD | PMID:18813882 |
| cocaine | increases expression | ISO | RGD:2535 | 6480464 | Cocaine results in increased expression of EDNRA protein | CTD | PMID:17420087 |
| cycloheximide | multiple interactions | ISO | RGD:2535 | 6480464 | Cycloheximide inhibits the reaction [Particulate Matter results in increased expression of EDNRA mRNA]; more ... | CTD | PMID:20561571 |
| daunorubicin | increases expression | ISO | RGD:2535 | 6480464 | Daunorubicin results in increased expression of EDNRA protein | CTD | PMID:20888384 |
| daunorubicin | multiple interactions | ISO | RGD:2535 | 6480464 | telmisartan inhibits the reaction [Daunorubicin results in increased expression of EDNRA protein] | CTD | PMID:20888384 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:2535 | 6480464 | Tetrahydrocannabinol results in increased expression of EDNRA mRNA | CTD | PMID:16616335 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of EDNRA mRNA | CTD | PMID:20003209 |
| diazoxide | multiple interactions | ISO | RGD:2535 | 6480464 | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of EDNRA mRNA] | CTD | PMID:18594475 PMID:20307649 |
| diazoxide | increases expression | ISO | RGD:2535 | 6480464 | Isoproterenol results in increased expression of EDNRA mRNA | CTD | PMID:18594475 PMID:20307649 |
| diazoxide | increases expression | ISO | RGD:2535 | 6480464 | Isoproterenol results in increased expression of EDNRA protein | CTD | PMID:20307649 |
| diazoxide | increases expression | ISO | RGD:2535 | 6480464 | Isoproterenol results in increased expression of EDNRA mRNA | CTD | PMID:20307649 PMID:18594475 |
| diazoxide | multiple interactions | ISO | RGD:2535 | 6480464 | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of EDNRA protein] | CTD | PMID:20307649 |
| diazoxide | multiple interactions | ISO | RGD:2535 | 6480464 | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of EDNRA mRNA] | CTD | PMID:20307649 PMID:18594475 |
| diazoxide | increases expression | ISO | RGD:2535 | 6480464 | Isoproterenol results in increased expression of EDNRA mRNA | CTD | PMID:18594475 |
| diazoxide | multiple interactions | ISO | RGD:2535 | 6480464 | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of EDNRA mRNA]; more ... | CTD | PMID:18594475 |
| dibutyl phthalate | increases expression | ISO | RGD:2535 | 6480464 | Dibutyl Phthalate results in increased expression of EDNRA mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of EDNRA mRNA | CTD | PMID:17361019 |
| dimethyl sulfoxide | multiple interactions | ISO | RGD:2535 | 6480464 | [Dimethyl Sulfoxide co-treated with Dactinomycin] results in decreased expression of EDNRA mRNA; more ... | CTD | PMID:20561571 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of EDNRA mRNA; more ... | CTD | PMID:21926265 |
| dioxygen | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA mRNA]; more ... | CTD | PMID:21926265 |
| disodium selenite | multiple interactions | EXP | | 6480464 | [ptaquiloside co-treated with Sodium Selenite] results in decreased expression of EDNRA mRNA | CTD | PMID:23274088 |
| doxorubicin | multiple interactions | ISO | RGD:2535 | 6480464 | [cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] affects the reaction [Doxorubicin results in increased activity of CASP3 protein] | CTD | PMID:14736733 |
| elemental selenium | multiple interactions | ISO | RGD:737537 | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of EDNRA mRNA | CTD | PMID:19244175 |
| elemental selenium | decreases expression | ISO | RGD:737537 | 6480464 | Selenium results in decreased expression of EDNRA mRNA | CTD | PMID:19244175 |
| fructose | multiple interactions | ISO | RGD:2535 | 6480464 | KLK1 protein inhibits the reaction [Fructose results in increased expression of EDNRA mRNA] | CTD | PMID:14568997 |
| fructose | increases expression | ISO | RGD:2535 | 6480464 | Fructose results in increased expression of EDNRA mRNA | CTD | PMID:9869011 PMID:14568997 |
| fructose | increases expression | ISO | RGD:2535 | 6480464 | Fructose results in increased expression of EDNRA mRNA | CTD | PMID:14568997 PMID:9869011 |
| fulvestrant | multiple interactions | ISO | RGD:737537 | 6480464 | [fulvestrant co-treated with Tamoxifen co-treated with ZD4054] results in decreased expression of EDNRA mRNA | CTD | PMID:19943105 |
| isoprenaline | multiple interactions | ISO | RGD:2535 | 6480464 | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of EDNRA mRNA]; more ... | CTD | PMID:18594475 |
| isoprenaline | multiple interactions | ISO | RGD:2535 | 6480464 | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of EDNRA mRNA] | CTD | PMID:18594475 PMID:20307649 |
| isoprenaline | increases expression | ISO | RGD:2535 | 6480464 | Isoproterenol results in increased expression of EDNRA mRNA | CTD | PMID:18594475 PMID:20307649 |
| isoprenaline | increases expression | ISO | RGD:2535 | 6480464 | Isoproterenol results in increased expression of EDNRA protein | CTD | PMID:20307649 |
| isoprenaline | increases expression | ISO | RGD:2535 | 6480464 | Isoproterenol results in increased expression of EDNRA mRNA | CTD | PMID:20307649 PMID:18594475 |
| isoprenaline | multiple interactions | ISO | RGD:2535 | 6480464 | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of EDNRA protein] | CTD | PMID:20307649 |
| isoprenaline | multiple interactions | ISO | RGD:2535 | 6480464 | CPU0213 inhibits the reaction [Isoproterenol results in increased expression of EDNRA mRNA] | CTD | PMID:20307649 PMID:18594475 |
| isoprenaline | increases expression | ISO | RGD:2535 | 6480464 | Isoproterenol results in increased expression of EDNRA mRNA | CTD | PMID:18594475 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of EDNRA mRNA | CTD | PMID:20003209 |
| monocrotaline | increases expression | ISO | RGD:2535 | 6480464 | Monocrotaline results in increased expression of EDNRA mRNA | CTD | PMID:20967148 |
| monocrotaline | increases expression | ISO | RGD:2535 | 6480464 | Monocrotaline results in increased expression of EDNRA mRNA | CTD | PMID:20967148 PMID:22022327 |
| monocrotaline | multiple interactions | ISO | RGD:2535 | 6480464 | Simvastatin inhibits the reaction [Monocrotaline results in increased expression of EDNRA mRNA] | CTD | PMID:22022327 |
| ouabain | increases expression | ISO | RGD:2535 | 6480464 | Ouabain results in increased expression of EDNRA mRNA | CTD | PMID:15477225 PMID:16982439 |
| ouabain | increases expression | ISO | RGD:2535 | 6480464 | Ouabain results in increased expression of EDNRA mRNA | CTD | PMID:16982439 PMID:15477225 |
| ouabain | increases expression | ISO | RGD:2535 | 6480464 | Ouabain results in increased expression of EDNRA protein | CTD | PMID:16982439 |
| ozone | decreases expression | ISO | RGD:2535 | 6480464 | Ozone results in decreased expression of EDNRA mRNA | CTD | PMID:16081523 |
| ozone | increases expression | ISO | RGD:2535 | 6480464 | Ozone results in increased expression of EDNRA mRNA | CTD | PMID:20980218 |
| paraquat | affects expression | ISO | RGD:2535 | 6480464 | Paraquat affects the expression of EDNRA mRNA | CTD | PMID:16854511 |
| phenylephrine | multiple interactions | ISO | RGD:2535 | 6480464 | [cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] which results in decreased susceptibility to Phenylephrine; more ... | CTD | PMID:15007106 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of EDNRA mRNA | CTD | PMID:16985257 |
| potassium chloride | multiple interactions | EXP | | 6480464 | [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] affects the activity of EDNRA protein | CTD | PMID:18516094 |
| raloxifene | multiple interactions | ISO | RGD:737537 | 6480464 | [Raloxifene co-treated with ESR2 protein] results in decreased expression of EDNRA mRNA; more ... | CTD | PMID:19059307 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Oxygen deficiency results in increased expression of EDNRA mRNA]; more ... | CTD | PMID:21926265 |
| selenium atom | multiple interactions | ISO | RGD:737537 | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of EDNRA mRNA | CTD | PMID:19244175 |
| selenium atom | decreases expression | ISO | RGD:737537 | 6480464 | Selenium results in decreased expression of EDNRA mRNA | CTD | PMID:19244175 |
| simvastatin | multiple interactions | ISO | RGD:2535 | 6480464 | Simvastatin inhibits the reaction [Cholesterol, Dietary results in increased expression of EDNRA mRNA]; more ... | CTD | PMID:19505368 |
| simvastatin | multiple interactions | ISO | RGD:2535 | 6480464 | Simvastatin inhibits the reaction [Monocrotaline results in increased expression of EDNRA mRNA] | CTD | PMID:22022327 |
| sodium chloride | multiple interactions | EXP | | 6480464 | [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] affects the activity of EDNRA protein | CTD | PMID:18516094 |
| sodium chloride | multiple interactions | ISO | RGD:2535 | 6480464 | [Desoxycorticosterone co-treated with Sodium Chloride] results in increased expression of EDNRA protein | CTD | PMID:22431579 |
| superoxide | affects abundance | ISO | RGD:2535 | 6480464 | EDNRA protein affects the abundance of Superoxides | CTD | PMID:12600921 |
| tacrolimus hydrate | increases activity | ISO | RGD:2535 | 6480464 | Tacrolimus results in increased activity of EDNRA protein | CTD | PMID:15964565 |
| tacrolimus hydrate | increases expression | ISO | RGD:2535 | 6480464 | Tacrolimus results in increased expression of EDNRA mRNA | CTD | PMID:8587392 |
| tamoxifen | multiple interactions | ISO | RGD:737537 | 6480464 | [fulvestrant co-treated with Tamoxifen co-treated with ZD4054] results in decreased expression of EDNRA mRNA; more ... | CTD | PMID:19943105 |
| tamoxifen | increases expression | ISO | RGD:737537 | 6480464 | Tamoxifen results in increased expression of EDNRA mRNA | CTD | PMID:19943105 |
| tamoxifen | multiple interactions | ISO | RGD:737537 | 6480464 | [Tamoxifen co-treated with ESR1 protein] results in increased expression of EDNRA mRNA; more ... | CTD | PMID:19059307 |
| telmisartan | multiple interactions | ISO | RGD:2535 | 6480464 | telmisartan inhibits the reaction [Daunorubicin results in increased expression of EDNRA protein] | CTD | PMID:20888384 |
| temozolomide | affects response to substance | ISO | RGD:737537 | 6480464 | EDNRA mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 |
| testosterone | affects expression | ISO | RGD:2535 | 6480464 | Testosterone affects the expression of EDNRA mRNA | CTD | PMID:12122504 PMID:14616470 |
| testosterone | affects expression | ISO | RGD:2535 | 6480464 | Testosterone affects the expression of EDNRA mRNA | CTD | PMID:14616470 PMID:12122504 |
| testosterone enanthate | affects expression | ISO | RGD:737537 | 6480464 | testosterone enanthate affects the expression of EDNRA mRNA | CTD | PMID:17440010 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of EDNRA mRNA | CTD | PMID:17484886 |